Q: Gud is beaten up so badly.So am I..Have a 3% pos.@ $10.11 for long time & additional 1% @ $7.37.Any news for last 2 days positive moves? Is it time to average down to 5% total? Txs for u usual great views & services
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I heard a comment on TV that any COVID-19 vaccine will have to be maintained at a very low temperature. Is this true ? If so, how significant do you think this could be for ABC and/or CYRX.
Thanks for your thoughts.
Ian
Thanks for your thoughts.
Ian
-
Merck & Company Inc. (MRK $87.37)
-
Pfizer Inc. (PFE $25.88)
-
GSK plc American Depositary Shares (Each representing two) (GSK $40.19)
Q: Hi 5i,
I'm not happy about the performance of GSK, what do you think about the performance going forward, also what else could you recommend for international exposure. Currently own Merk and Pfizer.
Thanks!
I'm not happy about the performance of GSK, what do you think about the performance going forward, also what else could you recommend for international exposure. Currently own Merk and Pfizer.
Thanks!
Q: please suggest a health car etf
Q: Could you please give some insight on GH and their new share issue @ $102.
Is this issue significant and why is the share price still above this level?
Is this a good sign?would you not think people would sell and buy back @ $102?
What are your thoughts going forward on GH?
Is this issue significant and why is the share price still above this level?
Is this a good sign?would you not think people would sell and buy back @ $102?
What are your thoughts going forward on GH?
Q: With the stock down now and with about $3.90 in cash, are their other businesses worth about $1.60 (5.50-3.90) Thanks
Q: There is one thing I don't understand. GUD bought Biotoscana one year ago I believe for almost $200M. The stock ran up 20% on that announcement to nearly $9 and now it is $5.50's. The thing I do not understand is didn't that acquisition do anything for the top or bottom line and hence give a positive light on the stock? You have said the last few months that investors are bored and waiting for an acquisition.
Isn't Biotoscana the acquisition? Thanks
Isn't Biotoscana the acquisition? Thanks
Q: Hi 5i,
Guardant Health or Neogenomics at current levels?
Thank you
Guardant Health or Neogenomics at current levels?
Thank you
Q: Your thoughts on OPK. Thanks.
Q: Why is the stock down today ? Add-on opportunity ? Thanks
Q: Hello Folks:
What are your feelings on united health care, or are there other choices?
Thanks for everything
brian
What are your feelings on united health care, or are there other choices?
Thanks for everything
brian
Q: Well is up big today do you know what's going on.
Q: Hi there,
Can I please get your thoughts on IPA here? I believe they plan to list on NASDAQ soon. What effect do you think this will have on the stock performance? What are your thoughts on the company's prospects? Would you be buying here?
Thanks!
Can I please get your thoughts on IPA here? I believe they plan to list on NASDAQ soon. What effect do you think this will have on the stock performance? What are your thoughts on the company's prospects? Would you be buying here?
Thanks!
-
Biogen Inc. (BIIB $139.31)
-
Gilead Sciences Inc. (GILD $114.77)
-
Illumina Inc. (ILMN $101.80)
-
Intuitive Surgical Inc. (ISRG $476.16)
-
Regeneron Pharmaceuticals Inc. (REGN $589.48)
-
AbbVie Inc. (ABBV $210.60)
-
Bristol-Myers Squibb Company (BMY $47.92)
-
Medtronic plc. (MDT $92.71)
-
Merck & Company Inc. (MRK $87.37)
-
Pfizer Inc. (PFE $25.88)
-
DexCom Inc. (DXCM $82.26)
-
Guardant Health Inc. (GH $61.40)
Q: I currently have PFE, GILD, MDT and ABBV in my Healthcare sector. I am looking to add a couple of names - I have been looking at MRK and BMY - your opinion please on these AND can you provide some other US healthcare companies that might be of interest to you at this time. Greatly appreciate your comments.
Thanks
Thanks
Q: As this stock has run up, I've gradually trimmed half of my position, thinking it's a Venture stock, which has meant that I kept it to 4% of my RRSP. Now they are listing on NASDAQ, but I'm thinking to sell more and go into WELL, realizing that while they are both in healthcare space, they are still very different stocks.
Which is more likely to position me for future growth?
Which is more likely to position me for future growth?
-
Amgen Inc. (AMGN $293.72)
-
AbbVie Inc. (ABBV $210.60)
-
Merck & Company Inc. (MRK $87.37)
-
Pfizer Inc. (PFE $25.88)
Q: Back in July 2020, I purchased ABBV, in a non-registered account, to get exposure to the healthcare sector and to continue to diversify my portfolio outside Canada. Since that time, I am down 16% on ABBV. Knowing 5i recommends ABBV, would you suggest I purchase more ABBV (average down)? Perhaps it would make more sense to sell it, take the tax loss, and purchase another healthcare company based outside of Canada. If your recommendation is to sell, what other healthcare sector companies would you suggest?
Q: Can I have your thoughts on Exelixis? Thank you
Peter
Peter
Q: Good day,
Wells Fargo analyst downgraded DXCM in addition to lowering its price target from $420 to $350. Has anything drastically changed and is it still worth holding? Thanks
Wells Fargo analyst downgraded DXCM in addition to lowering its price target from $420 to $350. Has anything drastically changed and is it still worth holding? Thanks
Q: I don't have any Healthcare. Between Pfizer and Johnson and Johnson, Which one do you prefer? Or both? Or neither?
Thanks
Jerry
Thanks
Jerry
Q: Could I have your comments on HLS's acquisition of a Portfolio of 4 royalty interests.
Thank-you.
Thank-you.